2025-10-05 - Analysis Report
Okay, here's a comprehensive analysis of Salesforce Inc. (CRM) based on the data provided.

## Salesforce Inc. (CRM) Analysis

**0. Executive Summary**

Salesforce Inc. (CRM), a leading provider of cloud-based software solutions, particularly in customer relationship management (CRM).  CRM is currently underperforming the S&P 500 significantly, with concerning recent performance metrics. Recent news and analyst opinions are mixed, pointing to potential AI-driven catalysts but also acknowledging existing challenges.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** CRM
*   **Company:** Salesforce Inc.
*   **Cumulative Return (CRM):** -11.41%
*   **Cumulative Return (VOO):** 98.51%
*   **Relative Deviation:**
    *   **Current:** -110.4
    *   **Max:** 54.1
    *   **Min:** -111.4
    *   **Relative Deviation (%):** 0.6
*   **Analysis:** CRM has significantly underperformed the S&P 500. The large negative deviation suggests substantial weakness relative to the broader market. The very low relative deviation percentage (0.6%) indicates the stock is near its lowest historical underperformance level relative to the S&P 500 within the observed data range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha  | Beta   | Cap(B) |
| ---------- | ------- | ------ | ------ | ------ | ------ |
| 2015-2017  | 39.0%   | 70.6%  | 10.0%  | -0.0   | 97.3   |
| 2016-2018  | 34.0%   | 73.5%  | 19.0%  | 0.1    | 130.4  |
| 2017-2019  | 22.0%   | 73.5%  | 0.0%   | 0.4    | 154.8  |
| 2018-2020  | 14.0%   | 73.5%  | -10.0%  | 0.4    | 211.8  |
| 2019-2021  | 37.0%   | 71.9%  | -10.0%  | 0.7    | 241.9  |
| 2020-2022  | -78.0%  | 74.7%  | -78.0%  | 0.4    | 126.2  |
| 2021-2023  | -47.0%  | 76.6%  | -49.0%  | -0.6   | 250.5  |
| 2022-2024  | -42.0%  | 76.6%  | -63.0%  | -0.4   | 318.3  |
| 2023-2025  | 0.0%    | 76.6%  | -63.0%  | -2.0   | 228.8  |

*   **Analysis:**
    *   **CAGR:** Decreasing trend in recent years, indicating slowing growth.
    *   **MDD:** High Maximum Drawdown values across all periods indicate significant price volatility.
    *   **Alpha:** Negative Alpha values in recent years indicate underperformance relative to the market.
    *   **Beta:** Fluctuating Beta values, even turning negative recently, suggest a changing relationship with the market.
    *   **Capitalization:** Company capitalization shows a general upward trend, though it decreased recently.

**2. Recent Price Action**

*   **Current Price:** 240.36
*   **Previous Close:** 238.88
*   **Change:** 0.62
*   **5-Day Moving Average:** 237.90
*   **20-Day Moving Average:** 243.31
*   **60-Day Moving Average:** 249.30

*   **Analysis:** The current price is slightly above the previous close, indicating a small recent gain. However, the 5-day moving average is below the 20-day and 60-day moving averages, which suggests a short-term downtrend. The price is below both the 20-day and 60-day averages, which can be interpreted as a bearish signal. The small change from the previous close suggests limited recent price momentum despite the bearish trend in moving averages.

**3. Technical Indicators**

*   **MRI:** 0.9 (Medium to High Investment Recommended)
*   **RSI:** 47.16 (Neutral, neither overbought nor oversold)
*   **PPO:** -0.17 (Slightly bearish, suggesting short-term weakness)
*   **Hybrid Signal:** Cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90)
*   **Recent (20-day) Relative Deviation Change:** 0.2 (+) (Short-term increase)
*   **Expected Return (%):** -4571.6 (Very negative; significant underperformance vs. S&P 500 projected over the long term with dollar-cost averaging)

*   **Analysis:**
    *   The MRI suggests a medium to high investment recommendation.
    *   RSI is neutral.
    *   The negative PPO indicates short-term bearish momentum.
    *   The hybrid signal suggests buying the stock with all available cash, implying a bullish strategy based on risk assessment.
    *   The recent increase in relative deviation indicates a potential short-term improvement in performance compared to the S&P 500.
    *   **Crucially, the expected return is extremely negative, signaling potential long-term underperformance.**
    *   The price change of 0.62 is small, not indicating a significant reaction or volatility spike.

**4. Recent News & Events**

*   **Key Headlines:**
    *   **AI Focus:** Several headlines discuss Salesforce's push into AI, including partnerships and potential catalysts for a rebound.
    *   **Analyst Sentiment:** At least one article notes a decline since the last earnings report, while another mentions potential pain ahead for software laggards.
    *   **Partnerships:** News of a 360-degree partnership with Perficient.
    *   **Funding News:** Outreach, Palantir, And Salesforce Veterans Raise $21M For Paid.ai To End Seat-Based SaaS Billing With AI Agent Infrastructure
*   **Analysis:** The news is mixed. While there's optimism around AI initiatives, there are also concerns about recent performance and broader software sector challenges. The AI push represents a potential future catalyst but requires execution.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.60)
*   **Opinions:** 51
*   **Target Price:**
    *   **Average:** 334.87
    *   **High:** 430.00
    *   **Low:** 221.00
*   **Recent Rating Changes:** Not Specified

*   **Analysis:** Despite the underperformance, analysts maintain a "Buy" consensus with a significant average target price well above the current price. However, a wide target price range suggests uncertainty.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
| ---------- | ---- | ---------- |
| 2025-09-04 | 1.97 | 10.24 B$   |
| 2025-05-29 | 1.61 | 9.83 B$    |
| 2024-12-04 | 1.6  | 9.44 B$    |
| 2024-08-29 | 1.48 | 9.32 B$    |
| 2025-09-04 | 1.48 | 9.32 B$    |

*   **Analysis:**
    *   EPS and Revenue are trending upwards.
    *   The latest data shows the highest EPS and Revenue figures in the provided dataset, suggesting positive growth momentum in the short term.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| ------------ | --------- | ------------- |
| 2025-07-31   | $10.24B   | 78.10%        |
| 2025-04-30   | $9.83B    | 76.96%        |
| 2025-01-31   | $9.99B    | 77.81%        |
| 2024-10-31   | $9.44B    | 77.71%        |
| 2024-07-31   | $9.32B    | 76.85%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
| ------------ | --------- | ------- |
| 2025-07-31   | $61.33B   | 3.08%   |
| 2025-04-30   | $60.67B   | 2.54%   |
| 2025-01-31   | $61.17B   | 2.79%   |
| 2024-10-31   | $58.52B   | 2.61%   |
| 2024-07-31   | $57.63B   | 2.48%   |

*   **Analysis:**
    *   **Revenue:** Shows a general increasing trend, indicating business growth.
    *   **Profit Margin:** Remains consistently high, indicating efficient operations and strong pricing power.
    *   **Equity:** Increasing trend, suggesting a strengthening balance sheet.
    *   **ROE:** Relatively stable, indicating consistent profitability on equity.

**7. Overall Assessment**

*   **Concerns:**  CRM is significantly underperforming the S&P 500.  The negative expected return raises serious concerns about long-term investment prospects. While analysts are bullish, the data suggests caution.
*   **Positives:** Recent earnings and revenue figures are encouraging. High profit margins and increasing equity suggest a financially healthy company. The AI push represents a potential catalyst.
*   **Overall:** The analysis presents a mixed picture. While CRM has strong financials and potential growth drivers, the significant underperformance, negative expected return, and mixed sentiment in recent news warrant a cautious approach. Investors should carefully weigh the risks and potential rewards, considering the company's ability to execute its AI strategy and improve its market performance. The analyst consensus suggests confidence in the stock's potential, but the negative technical indicators and comparative underperformance should not be ignored.
